These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20804250)

  • 21. Stability of cognitive performance in older patients with schizophrenia: an 8-week test-retest study.
    Harvey PD; Palmer BW; Heaton RK; Mohamed S; Kennedy J; Brickman A
    Am J Psychiatry; 2005 Jan; 162(1):110-7. PubMed ID: 15625208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Smith RC; Lindenmayer JP; Davis JM; Cornwell J; Noth K; Gupta S; Sershen H; Lajtha A
    Schizophr Res; 2009 May; 110(1-3):149-55. PubMed ID: 19251401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in cognitive function associated with syndrome changes on two five-factor models of the Positive and Negative Syndrome Scale.
    Jerrell JM; Hrisko S
    Hum Psychopharmacol; 2012 Nov; 27(6):566-76. PubMed ID: 23817989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies.
    Goldberg TE; Keefe RS; Goldman RS; Robinson DG; Harvey PD
    Neuropsychopharmacology; 2010 Apr; 35(5):1053-62. PubMed ID: 20090669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
    Hill SK; Keshavan MS; Thase ME; Sweeney JA
    Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: use of mixed-model analyses.
    Nayak Savla G; Moore DJ; Roesch SC; Heaton RK; Jeste DV; Palmer BW
    Schizophr Res; 2006 Apr; 83(2-3):215-23. PubMed ID: 16507344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia, cognition, and aging: cognitive deficits and the relationship between test performance and aging.
    Valsdottir V; Haraldsson M; Gylfason HF; Sigurdsson E; Magnusdottir BB
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Jan; 27(1):40-51. PubMed ID: 30707655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study.
    Lee J; Green MF; Nuechterlein KH; Swerdlow NR; Greenwood TA; Hellemann GS; Lazzeroni LC; Light GA; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Gur RC; Gur RE; Braff DL
    PLoS One; 2020; 15(5):e0232855. PubMed ID: 32401791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.
    Bombin I; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; de la Serna E; Rapado-Castro M; Barbeito S; Parellada M; Baeza I; Graell M; Payá B; Arango C
    Psychol Med; 2013 Apr; 43(4):757-68. PubMed ID: 22831788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
    Purdon SE; Jones BD; Stip E; Labelle A; Addington D; David SR; Breier A; Tollefson GD
    Arch Gen Psychiatry; 2000 Mar; 57(3):249-58. PubMed ID: 10711911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.
    Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R
    JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia.
    Gold S; Arndt S; Nopoulos P; O'Leary DS; Andreasen NC
    Am J Psychiatry; 1999 Sep; 156(9):1342-8. PubMed ID: 10484943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior intellectual ability in schizophrenia: neuropsychological characteristics.
    MacCabe JH; Brébion G; Reichenberg A; Ganguly T; McKenna PJ; Murray RM; David AS
    Neuropsychology; 2012 Mar; 26(2):181-90. PubMed ID: 22201301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia.
    Muralidharan A; Finch A; Bowie CR; Harvey PD
    Schizophr Res; 2018 Jun; 196():29-34. PubMed ID: 28778553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.